Skip to main content

Table 1 Renal function parameter measurements at the end of the study (day 45)

From: Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease

Parameters

Groups

Sham

CKD

RPC

hiPSC

Body weight change (g)

61.6 ± 36.2a

− 23.6 ± 101b,c

56.7 ± 23

59.7 ± 14

Mean arterial pressure (mmHg)

127 ± 1

201 ± 23

172 ± 30

177 ± 37

CCr (mL/min)

1 ± 0.1

0.85 ± 0.1d

0.91 ± 0.5e

1.61 ± 0.5

RCCr (mL/min/day)

0.001 ± 0.003

0.01 ± 0.01

0.005 ± 0.01

0.002 ± 0.008

SCr (mg/dL)

0.6 ± 0.1f

1.06 ± 0.5

0.87 ± 0.24

0.85 ± 0.13

PT24h (mg/24 h)

10 ± 0.2g

44.5 ± 22.6

45.8 ± 30

36 ± 21

  1. Results are presented as mean ± SD. Abbreviations: SCr serum creatinine, RCCr rate of decline of CCr, PT24h 24-h proteinuria, CCr creatinine clearance, CKD chronic kidney disease, RPC renal progenitor cell, hiPSC induced pluripotent stem cell. ap < 0.05 vs. CKD; b,cp < 0.05 vs. RPC and hiPSC; dp < 0.05 vs. hiPSC; ep < 0.05 vs. hiPSC, CKD; fp < 0.01 vs. CKD; gp < 0.01 vs. CKD vs. RPC vs. hiPSC